Antiviral potential of Curcuma longa L.
Keywords:
curcuma, curcumin, anti-infective properties, virusesAbstract
Curcuma longa L. and its compound curcuminoids have pleiotropic activity, including anti-inflammatory, anti-oxidant, anti-tumor, antimicrobial and antiviral activities. Numerous studies have shown that antiviral activities for rhizome extracts of C. longa and curcuminoids possesses a wide spectrum of biological and pharmacological properties against different viruses like the influenza virus, hepatitis B and C viruses, HIV etc. Mechanisms antiviral activity of curcuminoids involve either a direct of interference of viral replication or suppression of cellular signaling pathways essential for viral replication. This review summarizes the current knowledge and future perspectives of the use of the antiviral effects of curcumin.
References
Большой энциклопедический словарь лекарственных растений. – СПб.: Спец Лит., 2015. – 296 с.
Золотые наночастицы: синтез, свойства, биомедицинское применение / П.М. Бычковский, А.А. Кладиев, С.О. Соломевич, С.Ю. Щеголев // Российский биотерапевтический журнал. – 2011. – №3. – С.37–46.
Медицинская вирусология. – М.: МИА, 2008. – С. 21.
Панавир в лечении вирусных инфекций (Сборник под ред. акад. РАМН, В.И. Сергиенко). – М.: 2005. – 5 с.
Подходы к антивирусной фитотерапии / Ю.А. Смирнов, Т.Л. Киселева, Ю.А. Смирнова, А.А. Карпеев // Традиционная медицина. – 2009. – №2(17). – С.47–59.
Смирнов, Ю.А. Подходы к фитотерапии ВИЧ-инфекции / Ю.А. Смирнов, Н.Н. Носик, Д.Н. Носик // Традиционная медицина. – 2017. – 4(51). – С.26–35.
Соловьёва, Н.Л. Биодоступность куркумина и методы её повышения. / Н.Л. Соловьёва, М.С. Сокуренко, О.А. Зырянов // Разработка и регистрация лекарственных средств. – 2018. – №3(24). – С.46–53.
Ali, A. Curcumin inhibits HIV-1 by promoting Tat protein degradation./ A. Ali, A.C. Banerjea // Scientific Reports. – 2016; 6, 27539:1–9.
Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells / C.C. Anggakusuma, L.M. Colpitts, H. Schang [et al.] // Gut. – 2014; 63 (7):1137–1149.
Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/ nonhistone proteins and histone acetyltransferase-dependent chromatin transcription / K. Balasubramanyam, R.A. Varier, M. Altaf [et al.] // J. Biol. Chem. – 2004; 279:51163–51171.
Curcumin and curcumin derivatives inhibit Tat-mediated transactivation of type 1 human immunodeficiency virus long terminal repeat / S. Barthelemy, L. Vergnes, L. Moynier [et al.] // Res. Virol. – 1998; 149: 43–52.
Plant products as topical microbicide candidates: assessment of in vitro and in vivo activity against herpes simplex virus type 2 / K.Z. Bourne, N. Bourne, S.F. Reising, L.R. Stanberry // Antiviral Research. – 1999; 42(3):219–226.
The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis / G.R. Campbell, E. Pasquier, J. Watkins [et al.] // J. Biol. Chem. – 2004; 279:48197–48204.
Curcumin inhibits influenza virus infection and haemagglutination activity / D.-Y. Chen, J.-H. Shien, L. Tiley [et al.] // Food Chemistry. – 2010; 119 (4):1346–1351.
Curcumin inhibits HCV replication by induction of heme oxygenase-1 and suppression of AKT / M.-H. Chen, M.-Y. Lee, J.-J. Chuang [et al.] // Int. J. Mol. Med. – 2012; 30:1021–1028.
Inhibition of enveloped viruses infectivity by curcumin / T.Y. Chen, D.Y. Chen, H.W. Wen [et al.] // PLoS ONE. – 2013; 8 (5): e62482.
??kr?k??, S. Biological activity of curcuminoids isolated from Curcuma longa./ S. ??kr?k??, E. Mozioglu, H. Y?lmaz // Records of Natural Products. – 2008; 2 (1): 19–24.
Inhibition of curcumin on influenza A virus infection and influenza pneumonia via oxidative stress, TLR2/4, p38/JNK MAPK and NF-?B pathways / J. Dai, L. Gu, Y. Su [et al.] // Int. Immunopharmacol. – 2018; 54: 177–187.
A novel curcumin-based vaginal cream Vacurin selectively eliminates apposed human cervical cancer cells / P.R. Debata, M.R. Castellanos, J.E. Fata [et al.] // Gynecol. Oncol. – 2013; 129: 145–153.
Dutta, K. Curcumin protects neuronal cells from Japanese encephalitis virus-mediated cell death and also inhibits infective viral particle formation by dysregulation of ubiquitin-proteasome system / K. Dutta, D. Ghosh, A. Basu // J. Neuroimmune Pharmacol. – 2009; 4: 328–337.
Fang, J.G. Thioredoxin reductase is irreversibly modified by curcumin – A novel molecular mechanism for its anticancer activity / J.G. Fang, J. Lu, A. Holmgren // J. of Biol. Chem. – 2005; 280 (26):25284–25290.
The anti-inflammatory activity of curcumin protects the genital mucosal epithelial barrier from disruption and blocks replication of HIV-1 and HSV-2 / V.H. Ferreira, A. Nazli, S.E. Dizzell [et al.] // PLoS One-2015; 10:e0124903. doi:10.1371/journal.pone.0124903.
Phase I dose-escalation trial of intravaginal curcumin in women for cervical dysplasia / L. Gattoc, P.M. Frew, S.N. Thomas [et al.] // Open Access J. Clin. Trials. – 2017; 9:1–10.
Dietary antioxidant curcumin inhibits microtubule assembly through tubulin binding./ K.K. Gupta, S.S. Bharne, K. Rathinasamy [et al.] // FEBS Journal. – 2006; 273 (23): 5320–5332.
Gupta, P. Comparative docking and CoMFA analysis of curcumine derivatives as HIV-1 integrase inhibitors / P. Gupta, P. Garg, N. Roy //Molecular Diversity. – 2011; 15 (3):733–750.
QSAR study of curcumine derivatives as HIV-1 integrase inhibitors / P. Gupta, A. Sharma, P. Garg, N. Roy // Current Computer-Aided Drug Design. – 2013; 9 (1):141–150.
Curcumin ameliorates severe influenza pneumonia via attenuating lung injury and regulating macrophage cytokines production / S. Han, J. Xu, X. Guo, M. Huang // Clin. Exp. Pharmacol. Physiol. – 2018; 45: 84–93.
The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cells / M. Hergenhahn, U. Soto, A. Weninger [et al.] // Molecular Carcinogenesis. – 2002; 33 (3):137–145.
Hsing-I Huang, Inhibition of EV71 by curcumin in intestinal epithelial cells / Hsing-I Huang, Chi-Chong Chio, Jhao-Yin Lin // PLOS ONE- 2018; 13(1): 1-20. https://doi.org/10.1371/journal.pone.0191617.
Joe, B. Biological properties of curcumin-cellular and molecular mechanisms of action / B. Joe, M. Vijaykumar, B.R. Lokesh // Critical Reviews in Food Science and Nutrition. – 2004; 44 (2):97–111.
Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication / H.J. Kim, H.S. Yoo, J.C. Kim [et al.] // J. Ethnopharmacol. – 2009; 124:189–196.
Curcumin inhibits hepatitis C virus replication via suppressing the Akt-SREBP-1 pathway / K. Kim, K.H. Kim, H.Y. Kim [et al.] // FEBS Lett. – 2010; 584:707–712.
Chemopreventive effect of Curcuma longa Linn on liver pathology in HBx transgenic mice / J. Kim, H.-L. Ha, H.-B. Moon [et al.] // Integr. Cancer Ther. 2011; 10:168–177.
Inhibition of HIV-1 by curcumin A, a novel curcumin analog / N. Kumari, A.A. Kulkarni, X. Lin [et al.] // Drug Des. Devel. Ther. – 2015; 9:5051–5060.
Transport of liposomal and albumin loaded curcumin to living cells: An absorption and fluorescence spectroscopic study / B. Kunwar, A. Barik, R. Pandey, K.I. Priyadarsini // Biochim. Biophys. Acta (Gen.). – 2006; 1760: 1513–1522.
Curcumin inhibits herpes simplex virus immediate-early gene expression by a mechanism independent of p300/CBP histone acetyl transferase activity / S.B. Kutluay, J. Doroghazi, M.E. Roemer, S.J. Triezenberg // Virology. – 2008; 373(2):239–247.
Direct inhibitory effect of curcumin on Src and focal adhesion kinase activity / T.H. Leu, S.L. Su, Y.C. Chuang, M.C. Maa // Biochemical Pharmacology. – 2003; 66 (12):2323–2331.
Li L. Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis./ L Li., F.S. Braiteh, R. Kurzrock // Cancer. – 2005; 104: 1322–1331. DOI: 10.1002/cncr.21300.
Protein phosphatase-1-targeted small molecules, iron chelators and curcumin analogs as HIV-1 antivirals / X. Lin, T. Ammosova, N. Kumari, S. Nekhai // Curr. Pharm. Des. – 2017; 23:4122–4132.
Curcumin inhibits human cytomegalovirus by downregulating heat shock protein 90 / Y. Lv, L. Gong, Z. Wang [et al.] // Molecular Medicine Reports. – 2015; 12 (3):4789–4793.
Protective effect of curcumin against cytomegalovirus infection in Balb/c mice / Y. Lv, N. Lei, D. Wang [et al.] // Environmental Toxicology and Pharmacology. – 2014; 37 (3): 1140–1147.
Computer aided screening of natural compounds targeting the E6 protein of HPV using molecular docking / S. Mamgain, P. Sharma, R. K . Pathak, M. Baunthiyal // Bioinformation. – 2015; 11: 236–242.
Mathew, D.C. Antiviral potential of curcumin / D.C. Mathew, W-L. Hsu // Journal of Functional Foods. – 2018; 40(692):699 DOI: 10.1016/j.jff.2017.12.017.
Inhibition of human immunodeficiency virus type-1 integrase by curcumin./ A. Mazumder, K. Raghavan, J. Weinstein [et al.] // Biochem. Pharmacol. – 1995; 49(8):1165–1170.
Mi?ob?dzka, J. Zur kenntnis des curcumins / J. Mi?ob?dzka, S. Kostanecki, V. Lampe // Ber. Deut. Chem. Ges. – 1910; 43:2163–2170.
Curcumin modulates cellular AP-1, NF-kB, and HPV16 E6 proteins in oral cancer / A. Mishra, R. Kumar, A. Tyagi [et al.] // Ecancer medical science. – 2015; 9:525.
A Review on Antibacterial, Antiviral, and Antifungal Activity of Curcumin / S.Z. Moghadamtousi, H.A. Kadir, P. Hassandarvish [et al.] // Biomed Res Int. – 2014; 2014: 186864. doi: 10.1155/2014/186864.
Curcumin inhibits Zika and chikungunya virus infection by inhibiting cell binding / B.C. Mounce, T. Cesaro, L. Carrau [et al.] // Antiviral Res. – 2017; 142:148–157.
Celastrol inhibits Tat-mediated human HIV transcription and replication / V. Narayan, K.C. Ravindra, C. Chiaro [et al.] // Journal of Molecular Biology. – 2011; 410 (5):972–983.
Curcumin inhibits Rift Valley fever virus replication in human cells / A. Narayanan, K. Kehn-Hall, S. Senina [et al.] // Journal of Biological Chemistry. – 2012; 287 (40):33198–33214.
Newman, D.J. Natural products as sources of new drugs from 1981 to 2014 / Newman D.J., Cragg G.M. // J. Nat. Prod. – 2016;79:629–661.
Curcumin prevents replication of respiratory syncytial virus and the epithelial responses to it in human nasal epithelial cells / K. Obata, T. Kojima, T. Masaki [ et al.] // PLoS ONE. – 2013; 8 (9):e70225.
Omosa, L.K. «Curcuma longa» in Therapeutic Potential Against Metabolic, Inflammatory, Infectious and Systemic Diseases / L.K. Omosa, J.O. Midiwo, V. Kuete // ed. Kuete V., editor. (Cambridge, MA: Academic Press;). – 2017:425–435.
Structure-activity relationship analysis of curcumin analogues on anti-influenza virus activity / J.-L. Ou, Y. Mizushina, S.-Y. Wang [et al.] // FEBS J. – 2013; 280:5829–5840.
Inhibitory effects of curcumin on dengue virus type 2-infected cells in vitro / S.L. Padilla, A. Rodriguez, M.M. Gonzales [et al.] // Archiv. of Virol. – 2014; 159 (3):573–579.
Anti-infective Properties of the Golden Spice Curcumin / D. Praditya, L. Kirchhoff, J. Br?ning [et al.] // Front Microbiol. – 2019; 10: 912: 1–18. doi: 10.3389/fmicb.2019.00912.
Priyadarsini, K.I. The Chemistry of Curcumin: From Extraction to Therapeutic Agent / K.I. Priyadarsini // Molecules. – 2014; 19: 291–212.
Ravindran, J. Curcumin and cancer cells: How many ways can curry kill tumor cells selectively? / J. Ravindran, S. Prasad, B.B. Aggarwa // AAPS Journal. – 2009; 11 (3):495–510.
Curcumin inhibits hepatitis B virus via down-regulation of the metabolic coactivator PGC-1alpha / M.M. Rechtman, O. Har-Noy, I. Bar-Yishay [et al.] // FEBS Letters. – 2010; 584 (11):2485–2490.
Reddy, S. Curcumin is a non-competitive and selective inhibitor of phosphorylase kinase / S. Reddy, & B.B. Aggarwal // FEBS Letters. – 1994; 341:19–22.
Innovative preparation of curcumin for improved oral bioavailability / H. Sasaki, Y. Sunagawa, K. Takahashi [et al.] // Biol. Pharm. Bull. – 2011; 34(5):660–665.
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 / M. Scheffner, B.A. Werness, J. M. Huibregtse [et al.] // Cell. – 1990; 63:1129–1136.
Docking study of HIV-1 reverse transcriptase with phytochemicals / A. Seal, R. Aykkal, R.O. Babu, M. Ghosh // Bioinformation. – 2011; 5 (10): 430–439.
Setlur A.S. Herbal lead as ideal bioactive compounds against probable drug targets of Ebola virus in comparison with known chemical analogue: A computational drug discovery perspective / A.S. Setlur, S.Y. Naik, S. Skariyachan // Interdisciplinary Sciences. – 2017; 9 (2):254–277.
Immunomodulatory activities of curcumin-stabilized silver nanoparticles: efficacy as an antiretroviral therapeutic / R.K. Sharma, K. Cwiklinski, R. Aalinkeel [et al.] // Immunol. Invest. – 2017; 46:833–846.
Dysregulation of the ubiquitin-proteasome system by curcumin suppresses coxsackievirus B3 replication / X. Si, Y. Wang, J. Wong [et al.] //Journal of Virology. – 2007;81(7):3142–3150.
Curcumin conjugated gold nanoparticle synthesis and its bioavailability./ K. Sindhu, A. Rajaram, K.J. Sreeram, R. Rajaram // RSC Adv. – 2014; 4:1808–1814.
Structure of curcumin in complex with lipoxygenase and its significance in cancer / E. Skrzypczak-Jankun, K. Zhou, N.P. McCabe [et al.] // Intern. J. Mol. Medicine. – 2003; 12 (1):17–24.
Sordillo, P.P. Curcumin suppression of cytokine release and cytokine storm. A potential therapy for patients with Ebola and other severe viral infections / P.P. Sordillo, L. Helson // In Vivo. – 2015; 29 (1):1-4.
Inhibition of the HIV-1 and HIV-2 proteases by curcumin and curcumin boron complexes / Z. Sui, R. Salto, J. Li [et al.] // Bioorganic & Medicinal Chemistry. – 1993; 1 (6):415–422.
Structural relationship of curcumin derivatives binding to the BRCT domain of human DNA polymerase lambda / T. Takeuchi, T. Ishidoh, H. Iijima [et al.] // Genes to Cells. – 2006; 11 (3):223–235.
Synergistic effects of thymoquinone and curcumin on immune response and anti-viral activity against avian influenza virus (H9N2) in turkeys / S. Umar, M.A.A. Shah, M.T. Munir [et al.] // Poult. Sci. – 2016; 95 1513–1520.
Active site binding modes of curcumin in HIV-1 protease and integrase / O. Vajragupta, P. Boonchoong, G.M. Morris, A.J. Olson // Bioorganic & Medicinal Chemistry Letters. – 2005; 15(14):3364–3368.
Curcumin inhibits hepatitis B virus infection by down-regulating cccDNA-bound histone acetylation / Z.-Q. Wei, Y.-H. Zhang, C.-Z. Ke [et al.] // World J. Gastroenterol. – 2017; 23:6252–6260.
Yang, X.X. Curcumin modified silver nanoparticles for highly efficient inhibition of respiratory syncytial virus infection / X.X. Yang, C.M. Li, & C.Z. Huang // Nanoscale. – 2016; 8(5):3040–3048.
Evaluation of antiviral activities of curcumin derivatives against HSV-1 in Vero cell line / K. Zandi, E. Ramedani, Mohammadi [et al.] // Natural Product Communications. – 2010; 5(12):1935–1938.
Two traditional Chinese medicines Curcumae radix and Curcumae Rhizoma: An ethnopharmacology, phytochemistry and pharmacology review / Y. Zhou, M. Xie, Y. Song [et al.] // Evidence-Based Complementary and Alternative Medicine. – 2016; 2016(3):1–30.
Curcumin inhibits bovine herpesvirus type 1 entry into MDBK cells / L. Zhu, X. Ding, D. Zhang [et al.] // Acta Virologica. – 2015; 59 (3):221–227.
Downloads
Published
How to Cite
Issue
Section
License
Reproduction of any materials without the written permission of the publisher is prohibited.
The responsibility for the accuracy of the information contained in articles and advertisements are the authors and advertisers.
